Align Technology Announces $200 Million Open Market Repurchase

Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign System of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it is planning to repurchase $200 million of Align’s common stock through open market repurchases under Align’s $1.0 billion stock repurchase program that was approved by Align's Board of Directors in April 2025.

“We are pleased to announce our intention to repurchase $200 million of our common stock through open market transactions. This decision reflects the continued confidence of management and the Board in our long-term strategy and market opportunity and underscores the strength of our balance sheet and strong cash flow generation,” said John Morici, Align CFO and executive vice president, global finance. “Align remains focused on executing its strategic plan, delivering superior outcomes for doctors and patients, and enhancing stockholder value by delivering sustainable growth and performance. In the face of a challenging and uncertain macroeconomic backdrop, we are navigating with a clear focus to control what we can and to continue to invest with discipline in the areas that will define our future.”

The open market repurchases of Align’s common stock will be executed pursuant to a Rule 10b5-1 trading plan. The timing and number of shares repurchased will be based on an evaluation of market conditions and other factors, including stock price, trading volume, general business and market conditions, and capital availability. The repurchases are expected to be completed by January 2026 and will be funded with Align’s cash on hand. As of June 30, 2025, Align had approximately 72.5 million shares outstanding and $901,157 million in cash and cash equivalents.

About Align Technology, Inc.

Align Technology designs and manufactures the Invisalign System, the most advanced clear aligner system in the world, iTero intraoral scanners and services, and exocad CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for over 286.4 thousand doctor customers and are key to accessing Align’s 600 million consumer market opportunity worldwide. Over the past 28 years, Align has helped doctors treat over 20.8 million patients with the Invisalign System and is driving the evolution in digital dentistry through the Align Digital Platform, our integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners. Visit www.aligntech.com for more information.

Schreibe Deinen Kommentar